C
CHRS
Coherus
1.520
+0.060+4.11%After Hours: 1.550 +0.030 +1.97%19:39 06/24 EDT
OPEN/PREV CLOSE1.500/1.460
TODAY RANGE1.480-1.555
VOL804.83K
MARKET CAP234.46M
52 WEEK RANGE0.7100-2.616
AVG VOL (3M)1.06M
% TURNOVER0.52%
TURNOVER--
P/E (TTM)0.9124
% RANGE5.14%
EPS(TTM)1.666
P/E(FORWARD)-1.3818
P/B2.982
BVPS0.5098
DIVIDEND--
P/S4.367
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP186.05M
SHARES OUTSTANDING154.25M
NEXT EARNINGS08/05-08/10
FREE FLOAT122.40M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
PUBT·06/15 20:41
Coherus Oncology dismisses EY, names PwC as new auditor
TipRanks·06/01 13:19
Coherus Biosciences Announces 2026 Stockholder Meeting Results
TipRanks·05/28 19:20
Analysts’ Top Healthcare Picks: Coherus Biosciences (CHRS), Medicinova (MNOV)
TipRanks·05/20 01:12
Coherus Biosciences Signals Momentum in Earnings Call
Seeking Alpha·05/13 10:00
Coherus Oncology: Setting Up For Important Readouts In Mid-2026
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.